News & Events
In Light of The 14th Rare Disease Day, How is China Doing on Rare Disease Drugs?
On February 28, 2021, the international community observes the 14th Rare Disease Day, which is a time of the year to raise awareness among the
The National Health Commission Announced the List of Second Batch of Encouraged Generic Drugs
On Dec 30, 2020, the National Health Commission (NHC) announced the list of second batch of encouraged generic drugs, including 19 drugs in which patents
The Pharmacopoeia of the People’s Republic of China 2020 Edition Officially Comes into Force.
The Pharmacopoeia of the People’s Republic of China 2020 Edition (hereinafter referred to as the Chinese Pharmacopoeia) officially comes into force on Dec 30, 2020.
China Promulgates 2021 Tariff Plan: Zero-tariff for Raw Materials of Anticancer Drugs and Orphan Drugs
On Dec. 21, 2020, China Ministry of Finance published the 2021 Tariff Adjustment Plan (hereafter referred to as “the Plan”). The Plan adjusts the provisional
2020 National Reimbursement Drug List (NRDL) Released
On Dec 28th, 2020, the National Healthcare Security Administration (NHSA) and Ministry of Human Resources and Social Security (MOHRSS) together issued the National Drug List
Re-registration of Drugs Produced Overseas, New Procedures and New Provisions
Introduction: Following the new Version of Measures for the Administration of Drug Registration, the new re-registration procedures for drugs manufactured overseas have been more detailed.